Clinical Trial

A Prospective, Randomized Clinical Study of Two Phakic Toric Implantable Lenses

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 21, 2025 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.
Summary
Primary Objective: To compare the efficacy and the residual refractive error of EYECRYLTM Phakic toric versus Visian® Toric ICL in moderate to high myopic patient with co-existing astigmatism. Secondary Objectives: To evaluate and compare the safety of EYECRYLTM Phakic toric versus Visian® Toric ICL in moderate to high myopic patients with co-existing astigmatism.
Trial Details
NCT Number NCT06839898
Lead Sponsor Biotech Healthcare Holding Gmbh
Conditions Myopia, Moderate, Myopic Astigmatism, Myopia, Degenerative
Enrollment 172 participants
Start Date 2021-10-10
Primary Completion 2025-08 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2025-02-21